Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | KPL Kwality Pharmaceuticals Limited Pharma · Small | VIMTALABS Vimta Labs Limited Pharma · Small | UNICHEMLAB Unichem Laboratories Limited Pharma · Small | MOREPENLAB Morepen Laboratories Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 55 | 57 | 69 | 27 |
| Verdict | FAIR VALUE | FAIR VALUE | UNDERVALUED | OVERVALUED |
| Style | Premium Compounder | Financial Turnaround | Deep Value | OVERVALUED |
| Piotroski | 8/9 | 8/9 | 8/9 | 7/9 |
| Valuation | 4/30 | 8/30 | 27/30 | 5/30 |
| Growth | 18/25 | 17/25 | 18/25 | 4/25 |
| Quality | 16/20 | 14/20 | 0/20 | 0/20 |
| Balance Sheet | 9/15 | 9/15 | 11/15 | 9/15 |
| Cash Flow | 4/10 | 4/10 | 8/10 | 4/10 |
| Price | ₹2,338.6 | ₹527.85 | ₹379.65 | ₹48.65 |
| P/E | 35.70 | 29.80 | 34.10 | 35.90 |
| P/B | 7.31 | 5.18 | 0.98 | 2.13 |
| ROE | 22.80% | 18.90% | 3.03% | 6.20% |
| ROCE | 24.20% | 25.20% | 3.99% | 8.05% |
| Debt / Equity | 0.39 | 0.01 | 0.18 | 0.17 |
| FCF Yield | — | 0.72% | 7.34% | — |
| Dividend Y | — | 0.38% | — | 0.41% |
| Altman Z | 8.04 | 8.97 | 3.60 | 5.41 |
| Promoter % | 54.87% | 35.85% | 70.22% | 35.66% |
| Mkt Cap (₹Cr) | 2426.00 | 2349.00 | 2671.00 | 2670.00 |
| Graham # | ₹683.63 | ₹199.55 | ₹558.46 | ₹29.79 |
| Fair PE | 42.0 | 42.0 | 42.0 | 5.4 |
| MoS % | +14.2% | +27.6% | +74.8% | -420.7% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startKPL144
VIMTALABS76
UNICHEMLAB42
MOREPENLAB58